Patents by Inventor Katharine Lacy Cain

Katharine Lacy Cain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9476081
    Abstract: The present invention relates to a recombinant host cell, wherein the cell is modified to increase the expression levels of Ero1 and XBP1 relative to the expression levels of Ero1 and XBP1 in an unmodified cell. The present invention also relates to a method of producing a recombinant protein of interest comprising expressing the recombinant protein of interest in the recombinant host cell.
    Type: Grant
    Filed: August 5, 2014
    Date of Patent: October 25, 2016
    Assignee: UCB Biopharma SPRL
    Inventors: Katharine Lacy Cain, Shirley Jane Peters, Paul Edward Stephens
  • Patent number: 9315565
    Abstract: The present invention relates to a recombinant host cell, wherein the cell is modified to increase the expression levels of Ero1 and XBP1 relative to the expression levels of Ero1 and XBP1 in an unmodified cell. The present invention also relates to a method of producing a recombinant protein of interest comprising expressing the recombinant protein of interest in the recombinant host cell.
    Type: Grant
    Filed: July 29, 2014
    Date of Patent: April 19, 2016
    Assignee: UCB Pharma, S.A.
    Inventor: Katharine Lacy Cain
  • Publication number: 20150252385
    Abstract: The present disclosure relates to a host cell transfected with a NHEJ protein or a functional fragment thereof or a polynucleotide encoding the same, wherein said polynucleotide sequence is under the control of a suitable promoter and the host cell is also transfected with an expression cassette comprising a polynucleotide sequence encoding at least one protein of interest, methods of preparing the host cells, plasmids and intermediates employed in the preparation of the same and use of the host cells to express to protein.
    Type: Application
    Filed: September 30, 2013
    Publication date: September 10, 2015
    Inventor: Katharine Lacy Cain
  • Publication number: 20150025128
    Abstract: The present invention relates to a recombinant host cell, wherein the cell is modified to increase the expression levels of Ero1 and XBP1 relative to the expression levels of Ero1 and XBP1 in an unmodified cell. The present invention also relates to a method of producing a recombinant protein of interest comprising expressing the recombinant protein of interest in the recombinant host cell.
    Type: Application
    Filed: August 5, 2014
    Publication date: January 22, 2015
    Inventors: Katharine Lacy Cain, Shirley Jane Peters, Paul Edward Stephens
  • Publication number: 20140356911
    Abstract: The present invention relates to a recombinant host cell, wherein the cell is modified to increase the expression levels of Ero1 and XBP1 relative to the expression levels of Ero1 and XBP1 in an unmodified cell. The present invention also relates to a method of producing a recombinant protein of interest comprising expressing the recombinant protein of interest in the recombinant host cell.
    Type: Application
    Filed: July 29, 2014
    Publication date: December 4, 2014
    Applicant: UCB PHARMA S.A.
    Inventor: Katharine Lacy Cain
  • Patent number: 8828719
    Abstract: The present invention relates to a recombinant host cell, wherein the cell is modified to increase the expression levels of Ero1 and XBP1 relative to the expression levels of Ero1 and XBP1 in an unmodified cell. The present invention also relates to a method of producing a recombinant protein of interest comprising expressing the recombinant protein of interest in the recombinant host cell.
    Type: Grant
    Filed: February 10, 2010
    Date of Patent: September 9, 2014
    Assignee: UCB Pharma, S.A.
    Inventors: Katharine Lacy Cain, Shirley Jane Peters, Paul Edward Stephens
  • Publication number: 20120094297
    Abstract: The present invention relates to a recombinant host cell, wherein the cell is modified to increase the expression levels of Ero1 and XBP1 relative to the expression levels of Ero1 and XBP1 in an unmodified cell. The present invention also relates to a method of producing a recombinant protein of interest comprising expressing the recombinant protein of interest in the recombinant host cell.
    Type: Application
    Filed: February 10, 2010
    Publication date: April 19, 2012
    Applicant: UCB PHARMA S.A.
    Inventors: Katharine Lacy Cain, Shirley Jane Peters, Paul Edward Stephens